25 studies were found.

1.		Completed	12 week,comparing safety of HMR1964 & insulin aspart used in continuous subcutaneous infusion in type 1 diabetes. Condition: Diabetes, type I
2.		No longer recruiting	ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere Condition: Prostate Cancer
3.		Recruiting	Breast Cancer Trial of an Investigational Drug versus Capecitabine in Male or Female Patients with Advanced Breast Cancer Conditions: Breast Cancer; Metastases
4.		Recruiting	Compare blood sugar level between Lantus in the morning and other insulins in Type 1 diabetes adolescents Condition: Diabetes Mellitus
5.		Recruiting	Determine whether glycemic control is different between Lantus & a 3rd oral agent when failure with other treatment Condition: Diabetes Mellitus
6.		No longer recruiting	Docetaxel in Treating Patients Who Have Undergone Surgery for Prostate Cancer Conditions: stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
7.		No longer recruiting	The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Conditions: Impaired Glucose Tolerance; Cardiovascular Disease; Glucose Metabolism Disorders
8.		No longer recruiting	Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma Condition: Asthma
9.		No longer recruiting	Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma Condition: Asthma
10.		Recruiting	Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) Conditions: Myocardial Infarction; Acute ST-segment elevation
11.		Recruiting	Enoxaparin versus Unfractionated Heparin in Subjects Who Present to the Emergency Department with Acute Coronary Syndrome (RESCUE) Condition: Acute coronary syndrome
12.		Recruiting	Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism in Patients Following Acute Ischemic Stroke (PREVAIL) Condition: Acute ischemic stroke
13.		Completed	Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients unresponsive to Maximum Dose Metformin & Thiazolidinedione Condition: Diabetes Mellitus, Non-Insulin-Dependent
14.		Recruiting	Extended Prophylaxis for Venous Thromboembolism (VTE) in Acutely Ill Medical Patients with Prolonged Immobilization (EXCLAIM) Condition: Venous Thromboembolism
15.		No longer recruiting	Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer Conditions: recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
16.		Recruiting	HP184 in Chronic Spinal Cord Injury Subjects Condition: Spinal Cord Injury
17.		Recruiting	An Investigational Drug in Male or Female Patients with Advanced Breast Cancer who no longer respond to Anthracycline, Taxane and Capecitabine Treatment Condition: Breast Cancer
18.		Terminated	Iressa/Docetaxel in Non-Small-Cell Lung Cancer Condition: Non-small cell lung cancer
19.		No longer recruiting	Long-term Safety Performance of Fexofenadine in Asthma Condition: Asthma
20.		Recruiting	Open Study of enoxaparin vs. unfractionated heparin in patients with acute coronary syndromes Conditions: Unstable Angina; Myocardial Infarction; Myocardial Ischemia
21.		Recruiting	The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention) Condition: Diabetes Mellitus, Non-Insulin-Dependent
22.		Completed	Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer Conditions: stage IV breast cancer; stage IIIA breast cancer; recurrent breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
23.		Completed	A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy Condition: Prostate Cancer
24.		Recruiting	Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE) Condition: Percutaneous Coronary Intervention
25.		Recruiting	Study of DN101 and Taxotere in Patients with Advanced Non-Small Cell Lung Cancer Condition: Carcinoma, Non-Small-Cell Lung